Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma

Cancer

Volumn 77, Issue 1, 1996, Pages 7-13

  Lam, King Yin ^a,b   Law, Simon Ying Kit ^b   So, Mike Ka Pui ^b   Fok, Manson ^b   Ma, Lily Tung ^a   Wong, John ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

differentiation; Ki 67; MIB 1; prognosis; proliferating cell nuclear antigen; squamous cell carcinoma

Indexed keywords

CYCLINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY KI 67; MONOCLONAL ANTIBODY PC 10; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NUCLEAR; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 13344281014     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960101)77:1<7::AID-CNCR3>3.0.CO;2-N     Document Type: Article

References (28)

1. Yu CCW, Filipe MI. Update on proliferation-associated antibodies applicable to formalin fixed paraffin embedded tissue and their clinical applications. Histochem J 1993; 25:843-53.
2. Yu CCW, Woods AJL, Levison DA. The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications. Histochem J 1992; 24:121-31.
3. Gerdes J, Schwab U, Lemke H, Stein H. Production of a monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31:13-20.
4. Fonatsch C, Duchrow M, Rieder H, Schluter C, Gerdes J. Assignment of the human Ki-67 gene (MK167) to 10q25-qter. Genomics 1991;11:476-7.
5. Key G, Becker MHG, Baron B, Duchrow M, Schluter C, Flad HD, et al. New Ki-67 equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 66 bp repetitive elements encoding for the Ki-67 epitope. Lab Invest 1993;68:629-36.
6. Schluter C, Duchrow M, Wohlenberg C, Becker MHG, Key G, Flad HD, et al. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 1993;123:513-22.
7. Meggetto F, Al Saati T, Cohen-Knafo E, Roubinet F, Selves J, Bouche G, et al. Production of a monoclonal antibody (IND.64) identifying a cell cycle-associated antigen using spleen cells from nude mice bearing Ichikawa tumour. J Pathol 1992;168:187-96.
8. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, et al. Monoclonal antibodies against recombinant parts of the K1-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
9. McCormick D, Chong H, Hobbs C, Datta C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB 1. Histopathology 1993;22:355-60.
10. Pisani P, Parkin DM, Ferlay J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993;55:891-903.
11. Furihata M, Ohtsuki Y, Ogoshi S, Takahashi A, Tamiya T, Ogata T. Prognostic significance of human papillomavirus genomes (type-16,-18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer 1993;54:226-30.
12. Nishihira T, Hashimoto Y, Katayama M, Mori S, Kuroki T. Molecular and cellular features of esophageal cancer cells. J Cancer Res Clin Oncol 1993;119:441-9.
13. Watanabe H, Jass JR, Sobin LH, in collaboration with pathologists in eight countries. Definition and explanatory notes. In: World Health Organization International histological classification of tumours: histological typing of oesophageal and gastric tumours. 2nd edition. Berlin: Springer-Verlag, 1990:11-18.
14. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ. Manual for staging of cancer. 4th edition. Philadelphia: JB Lippincott, 1992:57-59.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;158:23-39.
16. Wang LD, Shi ST, Zhou Q, Goldstein S, Hong JY, Shao P, et al. Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis. Int J Cancer 1994;59:514-9.
17. Hall PA, Levison DA, Woods AL, Yu CCW, Kellock DB, Watkins JA, et al. Proliferation cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1980;162:285-94.
18. Yu CCW, Fletcher CDM, Newman PL, Goodlad JR, Burton JC, Levison DA. A comparison of proliferative cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours. J Pathol 1992;166:147-52.
19. 2 + M phase fraction (flow cytometric analysis) and prognosis. Histopathology 1991;19:21-27.
20. Hickey K, Grehan D, Reid IM, O'Briain S, Walsh TN, Hennessy TPJ. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy. Cancer 1994;74:1693-98.
21. Miyazaki S, Sasano H, Suzuki T, Sawai T, Nishihira T, Mori S. Nucleolar organizer regions in human esophageal disorders: comparison with proliferating cell nuclear antigen by immunostaining. Mod Pathol 1992;5:396-401.
22. Jankowski J, McMenemin R, Yu C, Hopwood D, Wormsley KG. Proliferating cell nuclear antigen in oesophageal diseases: correlation with transforming growth factor alpha expression. Gut 1992;33:587-91.
23. Porschen R, Classen S, Piontek M, Borchard F. Vascularization of carcinomas of the esophagus and its correlation with tumor proliferation. Cancer Res 1994;54:587-91.
24. Porschen R, Kriegel A, Langen C, Classen S, Hilse M, Lohe B, et al. Assessment of proliferative activity in carcinomas of the human alimentary tract by Ki-67 immunostaining. Int J Cancer 1991;47:686-91.
25. Jaskiewicz K, DeGroot KM. p53 gene mutants expression, cellular proliferation and differentiation in oesophageal carcinoma and non-cancerous epithelium. Anticancer Res 1994;14:137-40.
26. Matsumura K, Tsuji T, Shinozaki F, Sasaki K, Takahashi M. Immunohistochemical determination of growth fraction in human tumors. Pathol Res Pract 1989;184:609-13.
27. Sasano H, Miyazaki S, Nishihira T, Sawai T, Nagura H. The proliferative cell fraction in cytology specimens: a study of human esophageal carcinoma. Am J Clin Pathol 1992;98:161-6.
28. Sasano H, Miyazaki S, Gooukon Y, Nishihira T, Sawai T, Nagura H. Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression. Hum Pathol 1992;23:1238-43.